πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 204 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12221414

Quaternary ammonium salt compound, preparation method therefor and use thereof

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY Β· Granted Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12215138

Compositions and methods for internalizing enzymes

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12157729

Solid state forms of Belumosudil and Belumosudil salts

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12139528

Treating refractory migraine

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12128034

Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

Iterum Therapeutics International Limited Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12109197

Combinations of Ξ²-lactam compounds and probenecid and uses thereof

Iterum Therapeutics International Limited Β· Granted Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12091388

Solid state forms of Reproxalap

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12005139

Ophthalmic formulations and related methods

ETERNATEAR, INC. Β· Granted Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11964047

Ophthalmic formulations and related methods

ETERNATEAR, INC. Β· Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11879003

Methods for increasing T-cell function

Kyverna Therapeutics, Inc. Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11813359

Sustained release olanzapine formulations

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11773083

Solid state forms of Belumosudil and Belumosudil salts

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11697639

Quaternary ammonium salt compound, preparation method therefor and use thereof

WEST CHINA HOSPITAL, SICHUAN UNIVERSITY Β· Granted Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11679078

Ophthalmic formulations and related methods

ETERNATEAR, INC. Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11679079

Ophthalmic formulations and related methods

ETERNATEAR, INC. Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11673860

Crystalline siponimod fumaric acid and polymorphs thereof

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11578135

Multispecific antigen-binding molecules binding to a target and an internalizing effector

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11555064

Treating headache comprising administering an antibody to calcitonin gene-related peptide

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11541177

Injection spring for aged prefilled syringe and auto injector

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11524017

Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs

Beijing Normal University Hong Kong Baptist University United International College Β· Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11478428

Combinations of beta-lactam compounds and probenecid and uses thereof

Iterum Therapeutics International Limited Β· Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11446253

Ionic liquids for internal delivery

The Regents of the University of California Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11447563

Tumor selective macropinocytosis-dependent rapidly internalizing antibodies

The Regents of the University of California Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11446357

Method for treating disease using FOXP3+CD4+ T cells

Kyverna Therapeutics, Inc. Β· Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted